Biologics Symposium 2026 – Dutch edition
Designed as a high-value environment where participants can connect, exchange expertise, build collaborations and identify practical routes to bring biologics to patients faster and more effectively.
Advanced biologics are reshaping therapeutic innovation, combining engineered proteins, antibodies, and cellular approaches to target disease with exceptional precision. The Netherlands hosts one of Europe’s most dynamic and collaborative immunotherapy ecosystems, making it an ideal setting to connect with leading experts and innovative companies.
Together we will explore:
• Early characterization strategies that reduce downstream surprises
• Innovative biologics platforms for oncology and beyond
• Emerging targets and new mechanism of action
• Novel antibody formats and functional profiling of mono- and multi-specific antibodies
Come for the insights. Stay for the conversations that move programs forward.